Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older at the time of signing the consent form
- People in Cohort A: those with a benign or cancerous colorectal (bowel) growth (ranging from early to moderate stage) who are suitable for surgery, and who have not previously received any cancer-fighting medications or radiation therapy
- People in Cohort B: those with a localised cancer of the colon or rectum who are suitable for surgery and who have already been treated with radiation therapy and/or pre-operative chemotherapy
- People who are able and willing to follow all the procedures required by the trial
- People who understand and voluntarily sign and date the consent form before any trial-related procedures begin
- People who have active medical insurance coverage
Who may not be able to join:
- People who are pregnant or currently breastfeeding
- People who have received immune-affecting medications (such as steroids or immunosuppressive treatments) within the 4 weeks before joining, or antibiotics within the 8 weeks before joining
- People who have, or have had, another type of cancer — unless that cancer is not expected to affect the trial results and the trial sponsor approves it (for example, certain treated skin cancers or cervical in-situ carcinoma may be acceptable; people previously treated for another cancer with no sign of return for at least 1 year may still be considered — confirm with trial site)
- People who have an inflammatory condition or an autoimmune disease
- People who are under legal guardianship, court-ordered protection, or similar legal arrangements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Matthieu SARABI, Dr, Centre Leon Berard
Phone: 04 26 55 68 24
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Characterization of colorectal tissue microenvironment of patients with locally colorectal neoplasia.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.